Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dentro, S.C. | - |
dc.contributor.author | Leshchiner, I. | - |
dc.contributor.author | Haase, K. | - |
dc.contributor.author | Tarabichi, M. | - |
dc.contributor.author | Wintersinger, J. | - |
dc.contributor.author | Deshwar, A.G. | - |
dc.contributor.author | Yu, K. | - |
dc.contributor.author | Rubanova, Y. | - |
dc.contributor.author | Macintyre, G. | - |
dc.contributor.author | Demeulemeester, J. | - |
dc.contributor.author | Vázquez-García, I. | - |
dc.contributor.author | Kleinheinz, K. | - |
dc.contributor.author | Livitz, D.G. | - |
dc.contributor.author | Malikic, S. | - |
dc.contributor.author | Donmez, N. | - |
dc.contributor.author | Sengupta, S. | - |
dc.contributor.author | Anur, P. | - |
dc.contributor.author | Jolly, C. | - |
dc.contributor.author | Cmero, M. | - |
dc.contributor.author | Rosebrock, D. | - |
dc.contributor.author | Schumacher, S.E. | - |
dc.contributor.author | Fan, Y. | - |
dc.contributor.author | Fittall, M. | - |
dc.contributor.author | Drews, R.M. | - |
dc.contributor.author | Yao, X. | - |
dc.contributor.author | Watkins, T.B.K. | - |
dc.contributor.author | Lee, J. | - |
dc.contributor.author | Schlesner, M. | - |
dc.contributor.author | Zhu, H. | - |
dc.contributor.author | Adams, D.J. | - |
dc.contributor.author | McGranahan, N. | - |
dc.contributor.author | Swanton, C. | - |
dc.contributor.author | Getz, G. | - |
dc.contributor.author | Boutros, P.C. | - |
dc.contributor.author | Imielinski, M. | - |
dc.contributor.author | Beroukhim, R. | - |
dc.contributor.author | Sahinalp, S.C. | - |
dc.contributor.author | Ji, Y. | - |
dc.contributor.author | Peifer, M. | - |
dc.contributor.author | Martincorena, I. | - |
dc.contributor.author | Markowetz, F. | - |
dc.contributor.author | Mustonen, V. | - |
dc.contributor.author | Yuan, K. | - |
dc.contributor.author | Gerstung, M. | - |
dc.contributor.author | Spellman, P.T. | - |
dc.contributor.author | Wang, W. | - |
dc.contributor.author | Morris, Q.D. | - |
dc.contributor.author | Wedge, D.C. | - |
dc.contributor.author | Van, Loo P. | - |
dc.contributor.author | Gonzalez, S. | - |
dc.contributor.author | Bowtell, D.D. | - |
dc.contributor.author | Campbell, P.J. | - |
dc.contributor.author | Cao, S. | - |
dc.contributor.author | Christie, E.L. | - |
dc.contributor.author | Cun, Y. | - |
dc.contributor.author | Dawson, K.J. | - |
dc.contributor.author | Eils, R. | - |
dc.contributor.author | Garsed, D.W. | - |
dc.contributor.author | Ha, G. | - |
dc.contributor.author | Jerman, L. | - |
dc.contributor.author | Lee-Six, H. | - |
dc.contributor.author | Mitchell, T.J. | - |
dc.contributor.author | Oesper, L. | - |
dc.contributor.author | Peto, M. | - |
dc.contributor.author | Raphael, B.J. | - |
dc.contributor.author | Salcedo, A. | - |
dc.contributor.author | Shi, R. | - |
dc.contributor.author | Shin, S.J. | - |
dc.contributor.author | Stein, L.D. | - |
dc.contributor.author | Spiro, O. | - |
dc.contributor.author | Vembu, S. | - |
dc.contributor.author | Wheeler, D.A. | - |
dc.contributor.author | Yang, T.-P. | - |
dc.date.accessioned | 2022-03-14T00:40:27Z | - |
dc.date.available | 2022-03-14T00:40:27Z | - |
dc.date.created | 2021-12-03 | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 0092-8674 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/138886 | - |
dc.description.abstract | Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important clinical challenge. However, the extent, origin, and drivers of ITH across cancer types are poorly understood. To address this, we extensively characterize ITH across whole-genome sequences of 2,658 cancer samples spanning 38 cancer types. Nearly all informative samples (95.1%) contain evidence of distinct subclonal expansions with frequent branching relationships between subclones. We observe positive selection of subclonal driver mutations across most cancer types and identify cancer type-specific subclonal patterns of driver gene mutations, fusions, structural variants, and copy number alterations as well as dynamic changes in mutational processes between subclonal expansions. Our results underline the importance of ITH and its drivers in tumor evolution and provide a pan-cancer resource of comprehensively annotated subclonal events from whole-genome sequencing data. © 2021 The Author(s) | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Elsevier B.V. | - |
dc.title | Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Shin, S.J. | - |
dc.identifier.doi | 10.1016/j.cell.2021.03.009 | - |
dc.identifier.scopusid | 2-s2.0-85103719722 | - |
dc.identifier.bibliographicCitation | Cell, v.184, no.8, pp.2239 - 2254.e39 | - |
dc.relation.isPartOf | Cell | - |
dc.citation.title | Cell | - |
dc.citation.volume | 184 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 2239 | - |
dc.citation.endPage | 2254.e39 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordAuthor | branching evolution | - |
dc.subject.keywordAuthor | cancer driver genes | - |
dc.subject.keywordAuthor | cancer evolution | - |
dc.subject.keywordAuthor | intra-tumor heterogeneity | - |
dc.subject.keywordAuthor | pan-cancer genomics | - |
dc.subject.keywordAuthor | subclonal reconstruction | - |
dc.subject.keywordAuthor | tumor phylogeny | - |
dc.subject.keywordAuthor | whole-genome sequencing | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.